2001
DOI: 10.1063/1.1435191
|View full text |Cite
|
Sign up to set email alerts
|

Compact superconducting 250 MeV proton cyclotron for the PSI PROSCAN proton therapy project

Abstract: A cyclotron for proton therapy has to fulfil many requirements set by the specific operational and safety needs of a medical facility and the medical environment. These are for instance high extraction efficiency, high availability and reliability, simple and robust operation. ACCEL Instruments GmbH has refined the design concept of a medical cyclotron for the PSI PROSCAN project with the objective to use this cyclotron as the standard accelerator in complete proton therapy facilities, which ACCEL intends to m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
7
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 0 publications
0
18
0
Order By: Relevance
“…Based on a proposal originating from 1993, ACCEL Instruments GmbH has designed a superconducting cyclotron for proton therapy in close collaboration with the National Superconducting Cyclotron Laboratory (NSCL) [1,2]. The cyclotron is a four sector azimuthally varying field isochronous superconducting compact machine with a central magnetic induction of 2:4 T and an extraction radius of 815 mm.…”
Section: Introductionmentioning
confidence: 99%
“…Based on a proposal originating from 1993, ACCEL Instruments GmbH has designed a superconducting cyclotron for proton therapy in close collaboration with the National Superconducting Cyclotron Laboratory (NSCL) [1,2]. The cyclotron is a four sector azimuthally varying field isochronous superconducting compact machine with a central magnetic induction of 2:4 T and an extraction radius of 815 mm.…”
Section: Introductionmentioning
confidence: 99%
“…For application in the field of proton therapy ACCEL developed a new 250 MeV superconducting cyclotron in cooperation with the National Superconducting Cyclotron Laboratory in Michigan, USA [1]. The first two cyclotrons of this type have been commissioned successfully and are integrated in proton therapy facilities, one at the Paul Scherrer Institute (PSI) in Switzerland and one at the Rinecker Proton Therapy Center (RPTC) in Germany [2].…”
Section: Introductionmentioning
confidence: 99%
“…The purpose of both machines is to produce 250 MeV protons for cancer treatment. Based on a conceptual design of NSCL [1], [2] these machines are the first ones of its kind being engineered and built by industry.…”
Section: Introductionmentioning
confidence: 99%